Clinical Trials Logo

Motor Neuropathy clinical trials

View clinical trials related to Motor Neuropathy.

Filter by:
  • None
  • Page 1

NCT ID: NCT05721040 Completed - Sensory Neuropathy Clinical Trials

Short-term Evaluation of Motor and Sensory Function in Post-COVID-19 Patients

Start date: October 1, 2021
Phase:
Study type: Observational

SARS-COV-2 infection reframed medical knowledge in many aspects, yet there is still a lot to be discovered. our aim is to evaluate neurological impact of covid-19; if there is any.

NCT ID: NCT05518136 Completed - Infant Development Clinical Trials

Evaluations of Cardiopulmonary Function and Motor Development of Congenital Heart Disease

Start date: April 10, 2021
Phase: N/A
Study type: Interventional

In this single-center, randomized controlled trial, patients (4-8 months) with CHD were randomly assigned to either a recovery group (home-based rehab exercise periodically) supervised by cellphone APP or to a control group. Left ventricular ejection fractions (LVEF), the rate of increase in heart rate (rHRI), and the rate of recovery heart rate (rHRR) were measured for representing cardiopulmonary capacity. The Alberta test and Neuro-intelligence Scale were used to evaluate their motor developmental outcomes. This study verified the feasibility of this rehab method and indicated that 6-month home-based exercise training can improve cardiopulmonary endurance and motor developmental level in infant CHD patients.

NCT ID: NCT05427422 Completed - Motor Neuropathy Clinical Trials

Stroke Recovery Research Based on EEG-fMRI

EEG-fMRI
Start date: June 30, 2022
Phase:
Study type: Observational

This study is aimed to investigate the post-stroke motor recovery of patients with ischemic stroke based on their neural features extracted from EEG-fMRI data.

NCT ID: NCT04054076 Completed - Diabetes Clinical Trials

10 Years Follow-up Study of Plantar Pressure, Kinetics and Kinematics in a Cohort of Patients Diagnosed With Diabetes

Diab10
Start date: January 1, 2020
Phase: N/A
Study type: Interventional

A combination of diabetes and neuropathy can cause an altered gait, increased tissue stiffness, limited joint mobility, muscle weakness, foot deformities, thus leading to excessive plantar pressure. The presence of an increased plantar pressure and the loss of sensation is a serious risk factor in the risk of development of diabetic foot ulcers (DFU). Therefore, appropriate shoes and insoles are recommended to redistribute high peak pressure (PP) and reduce pressure time integral (PTI) . Shoe modifications and insoles, when used, is effective to prevent the recurrence of plantar ulcer. The primary aim of the study was to: explore gait characteristics, kinetics and kinematics in a cohort of patients diagnosed with diabetes, with and without neuropathy, assigned to use different types of insoles. The second aim was to assess the relation between gait characteristics, kinetics and kinematics to high plantar PP and PTI. The third aim was to compare gait characteristics, kinetics and kinematics of patients with diabetes and healthy controls.